AstraZeneca PLC (NASDAQ:AZN)
| 53.75 Delayed Data As of Dec 04 |  +0.96 / +1.83%Today’s Change | 36.15 Today|||52-Week Range 64.94 | +7.79% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 52.78 |
| Today’s open | 53.55 |
| Day’s range | 53.43 - 54.13 |
| Volume | 194,789 |
| Average volume (3 months) | 5,043,448 |
| Market cap | $138.1B |
Data as of 3:59pm ET, 12/04/2020
Growth & Valuation
| Earnings growth (last year) | -39.32% |
| Earnings growth (this year) | +20.40% |
| Earnings growth (next 5 years) | +16.80% |
| Revenue growth (last year) | +11.03% |
| P/E ratio | 56.6 |
| Price/Sales | 5.30 |
| Price/Book | 10.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +4.39 | +3.05% |
| BMYBristol-Myers Squibb | +0.53 | +0.86% |
| SNYSanofi | +0.90 | +1.80% |
| NVONovo Nordisk | +0.57 | +0.85% |
Data as of 4:19pm ET, 12/04/2020
Financials
| Next reporting date | February 11, 2021 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $1.3B |
| Net profit margin | 5.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
